Literature DB >> 15605136

The management of chronic viral hepatitis: a Canadian consensus conference 2004.

Morris Sherman1, Vincent Bain, Jean-Pierre Villeneuve, Robert P Myers, Curtis Cooper, Steven Martin, Catherine Lowe.   

Abstract

Several government and nongovernment organizations held a consensus conference on the management of acute and chronic viral hepatitis to update previous management recommendations. The conference became necessary because of the introduction of new forms of therapy for both hepatitis B and hepatitis C. The conference issued recommendations on the investigation and management of chronic hepatitis B, including the use of lamivudine, adefovir and interferon. The treatment of hepatitis B in several special situations was also discussed. There were also recommendations on the investigation and treatment of chronic hepatitis C and hepatitis C-HIV coinfection. In addition, the document makes some recommendations about the provision of services by provincial governments to facilitate the delivery of care to patients with hepatitis virus infection. The present document is meant to be used by practitioners and other health care providers, including public health staff and others not directly involved in patient care.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15605136     DOI: 10.1155/2004/201031

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  16 in total

1.  Evidence-based clinical guidelines for immigrants and refugees.

Authors:  Kevin Pottie; Christina Greenaway; John Feightner; Vivian Welch; Helena Swinkels; Meb Rashid; Lavanya Narasiah; Laurence J Kirmayer; Erin Ueffing; Noni E MacDonald; Ghayda Hassan; Mary McNally; Kamran Khan; Ralf Buhrmann; Sheila Dunn; Arunmozhi Dominic; Anne E McCarthy; Anita J Gagnon; Cécile Rousseau; Peter Tugwell
Journal:  CMAJ       Date:  2010-06-07       Impact factor: 8.262

2.  Percutaneous liver biopsy: reflections and refinements.

Authors:  Cameron N Ghent
Journal:  Can J Gastroenterol       Date:  2006-02       Impact factor: 3.522

3.  Hepatocellular carcinoma in a large Canadian urban centre: stage at treatment and its potential determinants.

Authors:  Korosh Khalili; Ravi Menezes; Leyla Kochak Yazdi; Hyun-Jung Jang; Tae Kyoung Kim; Suraj Sharma; Jordan Feld; Morris Sherman
Journal:  Can J Gastroenterol Hepatol       Date:  2014-03

4.  Canadian consensus on medically acceptable wait times for digestive health care.

Authors:  William G Paterson; William T Depew; Pierre Paré; Denis Petrunia; Connie Switzer; Sander J Veldhuyzen van Zanten; Sandra Daniels
Journal:  Can J Gastroenterol       Date:  2006-06       Impact factor: 3.522

Review 5.  Hepatitis C: a review for primary care physicians.

Authors:  Tom Wong; Samuel S Lee
Journal:  CMAJ       Date:  2006-02-28       Impact factor: 8.262

6.  The effectiveness of ultrasound surveillance for hepatocellular carcinoma in a Canadian centre and determinants of its success.

Authors:  Korosh Khalili; Ravi Menezes; Tae Kyoung Kim; Leyla Kochak Yazdi; Hyun-Jung Jang; Suraj Sharma; Jordan Feld; Morris Sherman
Journal:  Can J Gastroenterol Hepatol       Date:  2015 Jun-Jul

Review 7.  Screening in liver disease.

Authors:  Paolo Del Poggio; Marzio Mazzoleni
Journal:  World J Gastroenterol       Date:  2006-09-07       Impact factor: 5.742

8.  Determinants of antiviral treatment initiation in a hepatitis C-infected population benefiting from universal health care coverage.

Authors:  Romain Moirand; Marc Bilodeau; Suzanne Brissette; Julie Bruneau
Journal:  Can J Gastroenterol       Date:  2007-06       Impact factor: 3.522

9.  Randomized controlled study investigating viral suppression and serological response following pre-S1/pre-S2/S vaccine therapy combined with lamivudine treatment in HBeAg-positive patients with chronic hepatitis B.

Authors:  Pham Thi Le Hoa; Nguyen Tien Huy; Le The Thu; Cao Ngoc Nga; Kazuhiko Nakao; Katsumi Eguchi; Nguyen Huu Chi; Bui Huu Hoang; Kenji Hirayama
Journal:  Antimicrob Agents Chemother       Date:  2009-09-21       Impact factor: 5.191

10.  Capacity enhancement of hepatitis C virus treatment through integrated, community-based care.

Authors:  Warren D Hill; Gail Butt; Maria Alvarez; Mel Krajden
Journal:  Can J Gastroenterol       Date:  2008-01       Impact factor: 3.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.